Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3887064

CC#CCn1c(=O)n(CCc2ccccc2)c2nc(Cl)nc(N3CCNCC3)c21.O=C(O)C(F)(F)F

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 13/20 0.50
FAP Q12884 5/20 0.42
P2RX3 P56373 1/20 0.40
DPP9 Q86TI2 1/20 0.39
ALDH1A1 P00352 4/20 0.39
CYP1A2 P05177 4/20 0.39
CYP3A4 P08684 4/20 0.39
CYP2D6 P10635 4/20 0.39
CYP2C9 P11712 4/20 0.39
HSD17B10 Q99714 4/20 0.39
CASP1 P29466 3/20 0.39
CASP7 P55210 2/20 0.39
HPGD P15428 2/20 0.39
USP2 O75604 3/20 0.39
CYP2C19 P33261 3/20 0.39
TP53 P04637 2/20 0.38
HIF1A Q16665 2/20 0.38
LMNA P02545 1/20 0.38
HTR3A P46098 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3885741 0.94 DPP4 (0.53) DPP4FAPP2RX3DPP9
SCHEMBL13866887 0.93 DPP4 (0.56) DPP4FAPDPP9ALDH1A1CYP1A2
Trifluoroacetic Acid SCHEMBL3877701 0.93 DPP4 (0.43) DPP4FAPP2RX3DPP9
Trifluoroacetic Acid SCHEMBL3875820 0.88 DPP4 (0.43) DPP4FAPP2RX3DPP9CYP2C9
Trifluoroacetic Acid SCHEMBL3883168 0.88 DPP4 (0.41) DPP4FAPP2RX3DPP9ALDH1A1
Trifluoroacetic Acid SCHEMBL3879690 0.87 DPP4 (0.52) DPP4FAPDPP9
Trifluoroacetic Acid SCHEMBL3885657 0.87 DPP4 (0.46) DPP4FAPP2RX3DPP9
Trifluoroacetic Acid SCHEMBL3875979 0.87 DPP4 (0.47) DPP4FAPDPP9ALDH1A1CYP1A2
Trifluoroacetic Acid SCHEMBL3877608 0.87 DPP4 (0.41) DPP4FAPP2RX3DPP9
SCHEMBL13866891 0.86 DPP4 (0.60) DPP4FAPP2RX3DPP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7524847-B2 Fused 1,3-dihydro-imidazole ring compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-04-28 US disclosed
US-20060111362-A1 1,3-Dihydroimidazole ring compound EISAI CO., LTD. (JP) 2006-05-25 US disclosed
EP-1568699-A1 1,3-DIHYDROIMIDAZOLE FUSED-RING COMPOUND Eisai Co., Ltd. (JP) 2005-08-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060111362-A1 1,3-Dihydroimidazole ring compound NR2C2, NR0B2, DPP4 DPP4 3/4885FAP 4451/4885P2RX3 1215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.